National Cancer Institute; Notice of Closed Meetings, 51032 [2012-20690]
Download as PDF
<![CDATA[
51032
Federal Register / Vol. 77, No. 164 / Thursday, August 23, 2012 / Notices
tkelley on DSK3SPTVN1PROD with NOTICES
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before Wednesday,
September 26, 2012. Oral presentations
from the public will be scheduled
between approximately 1 p.m. and 1:30
p.m. Those individuals interested in
making formal oral presentations should
notify the contact person and submit a
brief statement of the general nature of
the evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before Tuesday, September 18, 2012.
Time allotted for each presentation may
be limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
Wednesday, September 19, 2012.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Martha
Monser at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: August 17, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2012–20782 Filed 8–22–12; 8:45 am]
BILLING CODE 4160–01–P
VerDate Mar<15>2010
16:59 Aug 22, 2012
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Program Project Meeting II.
Date: October 3–4, 2012,
Time: 3:00 p.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications,
Place: National Institutes of Health
Neuroscience Center 6001 Executive
Boulevard Room A1/A2 Rockville, MD
20852.
Contact Person: Shakeel Ahmad, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH
6116 Executive Boulevard, Room 8139
Bethesda, MD 20892–8328, (301) 594–0114,
ahmads@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Program Project Meeting III.
Date: October 10–11, 2012.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center 5701 Marinelli Road
Bethesda, MD 20852.
Contact Person: Jeannette F. Korczak,
Ph.D., Scientific Review Officer Research
Programs Review Branch Division Of
Extramural Activities National Cancer
Institute, NIH 6116 Executive Blvd., Room
8115 Bethesda, MD 20892 301–496–9767,
korczakj@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Program Project Meeting IV.
Date: October 15–16, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville 1750
Rockville Pike Rockville, MD 20852.
Contact Person: Caterina Bianco, MD,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Cancer
Institute, NIH 6116 Executive Blvd., Ste.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
8134 Bethesda, MD 20892–8328, 301–496–
7011, biancoc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Program Project Meeting V.
Date: October 18, 2012
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Cancer Institute, 6116 Executive
Boulevard, DEA Conference Room 8018,
Rockville, MD 20852.
Contact Person: Virginia P. Wray, Ph.D.,
Deputy Chief, Research Programs Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH 6116
Executive Blvd., Room 8125, Bethesda, MD
20892,–8328, 301–496–9236,
wrayv@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: August 17, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–20690 Filed 8–22–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Cancer and Lipids.
E:\FR\FM\23AUN1.SGM
23AUN1
]]>Agencies
[Federal Register Volume 77, Number 164 (Thursday, August 23, 2012)]
[Notices]
[Page 51032]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-20690]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, NCI Program Project Meeting II.
Date: October 3-4, 2012,
Time: 3:00 p.m. to 9:00 p.m.
Agenda: To review and evaluate grant applications,
Place: National Institutes of Health Neuroscience Center 6001
Executive Boulevard Room A1/A2 Rockville, MD 20852.
Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH 6116 Executive Boulevard, Room 8139
Bethesda, MD 20892-8328, (301) 594-0114, ahmads@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, NCI Program Project Meeting III.
Date: October 10-11, 2012.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center 5701
Marinelli Road Bethesda, MD 20852.
Contact Person: Jeannette F. Korczak, Ph.D., Scientific Review
Officer Research Programs Review Branch Division Of Extramural
Activities National Cancer Institute, NIH 6116 Executive Blvd., Room
8115 Bethesda, MD 20892 301-496-9767, korczakj@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, NCI Program Project Meeting IV.
Date: October 15-16, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville 1750 Rockville Pike
Rockville, MD 20852.
Contact Person: Caterina Bianco, MD, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Cancer
Institute, NIH 6116 Executive Blvd., Ste. 8134 Bethesda, MD 20892-
8328, 301-496-7011, biancoc@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, NCI Program Project Meeting V.
Date: October 18, 2012
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Cancer Institute,
6116 Executive Boulevard, DEA Conference Room 8018, Rockville, MD
20852.
Contact Person: Virginia P. Wray, Ph.D., Deputy Chief, Research
Programs Review Branch, Division of Extramural Activities, National
Cancer Institute, NIH 6116 Executive Blvd., Room 8125, Bethesda, MD
20892,-8328, 301-496-9236, wrayv@mail.nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS).
Dated: August 17, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-20690 Filed 8-22-12; 8:45 am]
BILLING CODE 4140-01-P
